Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Breast cancer Clinical Trials

Protocol Number Title
2008NTLS060
The Effect of Enalapril on Doxorubicin Exposure in Adjuvant Breast Cancer Treatment
2008NTLS083
A Phase I/II Trial of Short Course Pre Operative Ritonavir To Determine Akt Inhibition in Breast Cancer
2009NTLS055
Improved Breast DCE MRI with SWIFT
2009UC147
Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2
2012IS079
A phase III randomized, double blind placebo controlled study of BKM120 with fulvestrant, in postmenopausal women with hormone receptor-positive HER2-negative locally advanced or metastatic breast cancer which progressed on or after aromatase inhibitor treatment
2012NTLS044
Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening
2013IS093
Multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of fulvestrant (faslodex) with or without PD-0332991 (Palbociclib) +/- Goserelin in women with hormone receptor-positive, HER2-negative metastatic breast cancer whose disease progressed after prior endocrine therapy
2013NTLS035
Vascular Assessment in Breast Cancer Survivors Taking Aromatase Inhibitors
2013NTLS063
Mobile Phone Multimedia Messaging Intervention for Breast Cancer Screening: Intervention Phase

9 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on